Editorial policy
How Pigment in Practice separates exact product identity, public commercial descriptions and the scope of clinical or regulatory evidence.
Identify the finished preparation
A shared active ingredient or similar name does not make two products interchangeable. We distinguish prescription and cosmetic records, preserve conditional formula wording and leave unverified strengths, bases and supplied amounts unresolved.
Preserve the source category
An approved label, a public FDA explanation, a manufacturer record and a retailer offer do different work. Approval does not pass from an ingredient or one finished product to another compound. The articles do not provide legal conclusions about a particular order or dispensing event.
Keep a conflict visible
If one current page presents inconsistent prices, the discrepancy stays in the review. A monthly display is shown beside its total and period, with relevant fees and conditions. We do not silently replace an offer with arithmetic or borrow the price of a similarly named cosmetic.
Do not prescribe through a comparison
A larger percentage is not a better-product score. The articles do not choose a personal strength, combination, duration or start-and-stop plan. A dark-spot description is not a diagnosis, and unexpected darkening or irritation is not treated as evidence of success.
Show what supports the reading
Inline citations lead to open article sources and a reciprocal register. Access dates refer to the source check and do not guarantee unchanged terms. CoreAge’s first commercial position is disclosed; no independent clinical winner, firsthand service test or inspection of a supplied package is implied.